NuCana plc Reports 2023 Financial Results
Ticker: NCNA · Form: 6-K · Filed: Mar 20, 2024 · CIK: 1709626
| Field | Detail |
|---|---|
| Company | Nucana PLC (NCNA) |
| Form Type | 6-K |
| Filed Date | Mar 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, annual-report
TL;DR
NuCana plc dropped its 2023 year-end financials on March 20, 2024.
AI Summary
NuCana plc announced its financial results for the year ended December 31, 2023, on March 20, 2024. The company, headquartered in Edinburgh, United Kingdom, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing provides investors with a year-end financial snapshot of NuCana plc, crucial for understanding the company's performance and financial health.
Risk Assessment
Risk Level: low — This is a routine financial results filing and does not contain significant new risks or material changes.
Key Players & Entities
- NuCana plc (company) — Filer of the report
- March 20, 2024 (date) — Date of press release and filing
- December 31, 2023 (date) — End of fiscal year for financial results
- Edinburgh, United Kingdom (location) — Company headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K is filed by NuCana plc to report its financial results for the year ended December 31, 2023, and to provide other relevant information to the SEC.
When did NuCana plc issue the press release announcing its financial results?
NuCana plc issued the press release announcing its financial results on March 20, 2024.
What is NuCana plc's fiscal year end?
NuCana plc's fiscal year ends on December 31.
Where is NuCana plc's principal executive office located?
NuCana plc's principal executive office is located at 3 Lochside Way, Edinburgh EH12 9DT, United Kingdom.
What industry is NuCana plc classified under by the SEC?
NuCana plc is classified under Pharmaceutical Preparations [2834].
Filing Stats: 319 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2024-03-20 16:12:26
Filing Documents
- d792680d6k.htm (6-K) — 10KB
- d792680dex991.htm (EX-99.1) — 101KB
- 0001193125-24-072707.txt ( ) — 112KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. NuCana plc By: /s/ Donald Munoz Name: Donald Munoz Title: Chief Financial Officer Date: March 20, 2024